The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug‐induced liver injury
Abstract
Summary: Background Drug‐induced liver injury may be immunologically mediated or metabolically induced. Peripheral eosinophilia and liver eosinophilia in suspected drug‐induced liver injury generally supports the role of drug aetiology. Aim To assess the importance of eosinophilia and hepatic necrosis on outcome in patients with suspected drug‐induced liver injury. Methods We performed search of MEDLINE for case reports on drug‐induced liver injury associated with: amoxicillin/clavulanic acid, carbamazepine, diclofenac, disulfiram, erythromycin, flucloxacillin, halothane, isoniazid, phenytoin, sulindac and trimethoprim/sulfametoxazol. Results A total of 570 case reports were retrieved. Mortality/transplantation occurred in 112 (20%). Eosinophilia in peripheral blood was reported in 34% of cases, eosinophilia in liver biopsies in 40%, and hepatic necrosis in 41%. Bilirubin levels were lower in patients with peripheral eosinophilia [5.5 × upper limit of normal (interquartile range 2.9–10) vs. 7.7 (4–17); P = 0.02] and patients with liver eosinophilia [5 × upper limit of normal (2.7–10) vs. 10 (5.4–20); P = 0.003] as compared with those without eosinophilia. Eosinophilia in peripheral blood and eosinophilia in liver biopsies were more common in patients who recovered (37% vs. 15.6%; P = 0.0001 and 48% vs. 18.8%; P < 0.0001, respectively). Hepatic necrosis was present in 24% in the survivors vs. 84% in non‐survivors (P < 0.0001). Conclusions In drug‐induced liver injury, a favourable outcome was related to the occurrence of eosinophilia, whereas hepatic necrosis was associated with a poor prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations were also noted in a meta‐analysis of DILI case reports.105”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Research works printed but not linked: 20
- Zimmerman HJ, 1999, Schiff’s Diseases of the liver, 973
- 10.1016/S0016-5085(19)32568-5 · DOI · Paper page
- 10.1016/j.jhep.2005.12.016 · DOI
- 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- 10.1016/S0168-8278(02)00231-3 · DOI
- 10.1053/jhep.2002.34857 · DOI · Paper page
- 10.1053/jhep.2001.20645 · DOI · Paper page
- 10.1002/hep.1840050617 · DOI
- 10.1002/hep.20800 · DOI · Paper page
- 10.1056/NEJM199805283382206 · DOI · Paper page
- 10.1056/NEJM199802123380706 · DOI · Paper page
- 10.1084/jem.179.2.703 · DOI · Paper page
- Desreumaux P, 1993, Synthesis of interleukin‐5 by activated eosinophils in patients with eosinophilic heart diseases, Blood, 82, 1553, 10.1182/blood.V82.5.1553.1553 · DOI
- 10.1016/S0168-8278(00)00057-X · DOI
- 10.1136/gut.2005.066423 · DOI
- Kanel GC, 2003, Drug‐induced liver disease
- 10.1111/j.1365-2796.1992.tb00562.x · DOI
- 10.1016/S1590-8658(00)80336-9 · DOI
- 10.1111/j.1365-2036.2006.03117.x · DOI · Paper page
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Metadata
- Authors
- BJÖRNSSON, E., KALAITZAKIS, E., & OLSSON, R.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-04-06
- Volume
- 25
- Issue
- 12
- Pages
- 1411-1421
- ISSN
- 0269-2813
- 1365-2036
- Cited by
- 137
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug‐induced liver injury. https://app.cochat.ai/papers/10.1111/j.1365-2036.2007.03330.x
- The paper
- BJÖRNSSON, E., KALAITZAKIS, E., & OLSSON, R. (2007). The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug‐induced liver injury. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2007.03330.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.